PharmaShots | Incisive News in 3 Shots

Subscribe Now

Bionomics

Bionomics Reports the Commencement of P-III (AFFIRM-1) Study Evaluating BNC210 for Social Anxiety Disorder (SAD)

Bionomics Reports the Commencement of P-III (AFFIRM-1) Study Evaluating BNC210 for Social Anxiety Disorder (SAD)

July 18, 2024

Bionomics Reports P-II Study (PREVAIL) Results of BNC210 for the Treatment of Social Anxiety Disorder

Bionomics Reports P-II Study (PREVAIL) Results of BNC210 for the Treatment of Social Anxiety Disorder

December 19, 2022

Bionomics Initiates P-II (PREVAIL) Study of BNC210 for the Acute Treatment of Social Anxiety Disorder

Bionomics Initiates P-II (PREVAIL) Study of BNC210 for the Acute Treatment of Social Anxiety Disorder

January 3, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us